Page 133 - Read Online

Micro RNA (miRNA) is a small non-coding RNA related Esophageal A, Barrett’s Esophagus Registry C, Chow WH,
to post-transcriptional gene expression and silencing. Murray LJ, Gammon MD, Liu G, Bernstein L, Casson AG,
Generally, up-regulation of oncogenic-miRNA or Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA,
down-regulation of tumor-suppressor miRNA is identifi ed Hardie LJ, Ye W, Wu AH, Zucchelli M, Spector TD, Hysi P,
Vaughan TL, Whiteman DC, MacGregor S, investigators
as tumor-related miRNAs. Mir-21 up-regulation has Bs. Germline genetic contributions to risk for esophageal
been observed in BE and EAC compared with normal adenocarcinoma, Barrett’s esophagus, and gastroesophageal
squamous cell epithelium and was associated with refl ux. J Natl Cancer Inst 2013;105:1711-8.
[69]
carcinogenesis. miRNA-194 was also induced in BE 9. Flejou JF. Barrett’s oesophagus: from metaplasia to dysplasia
and EAC and found to be related to intestinal metaplasia and cancer. Gut 2005;54 Suppl 1:i6-12.
and metastasis. [70,71] miRNA-143, which suppresses 10. American Gastroenterological A, Spechler SJ, Sharma P,
transcription of KRAS, was down-regulated in EAC and Souza RF, Inadomi JM, Shaheen NJ. American
gastroenterological association medical position statement
associated with TP53. [72,73] miRNA-31 and miRNA-375 on the management of Barrett’s esophagus. Gastroenterology
were found to be down-regulated in EAC and are early 2011;140:1084-91.
and late-stage markers of EAC carcinogenesis. [74] 11. Spechler SJ, Goyal RK. Barrett’s esophagus. N Engl J Med
1986;315:362-71.
Conclusion 12. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK.
The histologic spectrum of Barrett’s esophagus. N Engl J Med
Recent advances of next-generation sequencing have 1976;295:476-80.
provided researchers with better understanding of 13. Thompson JJ, Zinsser KR, Enterline HT. Barrett’s metaplasia
genetic and epigenetic alterations in EAC carcinogenesis. and adenocarcinoma of the esophagus and gastroesophageal
However, little study has examined those genetic junction. Hum Pathol 1983;14:42-61.
and epigenetic alterations in combination with 14. Chang CL, Lao-Sirieix P, Save V, De la Cueva Mendez G,
clinicopathological factors. In order to elucidate the Laskey R, Fitzgerald RC. Retinoic acid-induced glandular
pathogenesis of BE and EAC and to fi nd molecules for differentiation of the oesophagus. Gut 2007;56:906-17.
biomarkers and targeting therapy, it will be necessary 15. Bellin C, de Wiza DH, Wiernsperger NF, Rosen P. Generation
to analyze those genetic alterations in combination with of reactive oxygen species by endothelial and smooth muscle
cells: infl uence of hyperglycemia and metformin. Horm Metab
clinical data in a large-scale cohort. Res 2006;38:732-9.
Financial support and sponsorship 16. Marchetti M, Caliot E, Pringault E. Chronic acid exposure
leads to activation of the cdx2 intestinal homeobox gene in a
Nil. long-term culture of mouse esophageal keratinocytes. J Cell
Sci 2003;116:1429-36.
Confl icts of interest 17. Kong J, Nakagawa H, Isariyawongse BK, Funakoshi S,
Silberg DG, Rustgi AK, Lynch JP. Induction of intestinalization
There are no confl icts of interest.
in human esophageal keratinocytes is a multistep process.
References Carcinogenesis 2009;30:122-30.
18. Kalabis J, Wong GS, Vega ME, Natsuizaka M, Robertson ES,
1. Rudiger Siewert J, Feith M, Werner M, Stein HJ. Herlyn M, Nakagawa H, Rustgi AK. Isolation and
Adenocarcinoma of the esophagogastric junction: results of characterization of mouse and human esophageal epithelial
surgical therapy based on anatomical/topographic classifi cation cells in 3D organotypic culture. Nat Protoc 2012;7:235-46.
in 1,002 consecutive patients. Ann Surg 2000;232:353-61. 19. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA,
2. Sobin L, Gospodarowicz M, Wittekind C. International union Trier JS. Distribution of cytokeratin markers in Barrett’s
against cancer. TNM Classifi cation of Malignant Tumours. specialized columnar epithelium. Gastroenterology
7th ed. Chichester, NJ: Wiley; 2010. 1997;112:760-5.
3. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, 20. Daniely Y, Liao G, Dixon D, Linnoila RI, Lori A, Randell SH,
Dunn M, Feuer EJ. T rends in esophageal adenocarcinoma Oren M, Jetten AM. Critical role of p63 in the development
incidence and mortality. Cancer 2013;119:1149-58. of a normal esophageal and tracheobronchial epithelium. Am J
4. Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Physiol Cell Physiol 2004;287:C171-81.
Taniguchi H, Shimoda T. Changing trends in the proportion 21. Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS,
of adenocarcinoma of the esophagogastric junction in a large Dagher R, Vincent M, Lu X, Bellizzi AM, Ho KY, Crum CP,
tertiary referral center in Japan. J Gastroenterol Hepatol Xian W, McKeon F. Residual embryonic cells as precursors of
2008;23:1662-5. a Barrett’s-like metaplasia. Cell 2011;145:1023-35.
5. Rubenstein JH, Shaheen NJ. Epidemiology, diagnosis, and 22. Que J, Luo X, Schwartz RJ, Hogan BL. Multiple roles for
management of esophageal adenocarcinoma. Gastroenterology Sox2 in the developing and adult mouse trachea. Development
2015; doi: 10.1053/j.gastro.2015.04.053. 2009;136:1899-907.
6. Spechler SJ. Barrett esophagus and risk of esophageal cancer: 23. Jacobs IJ, Ku WY, Que J. Genetic and cellular mechanisms
a clinical review. JAMA 2013;310:627-36. regulating anterior foregut and esophageal development. Dev
7. Chandra S, Gorospe EC, Leggett CL, Wang KK. Barrett’s Biol 2012;369:54-64.
esophagus in 2012: updates in pathogenesis, treatment, and 24. Ishizuya-Oka A, Hasebe T. Sonic hedgehog and bone
surveillance. Curr Gastroenterol Rep 2013;15:322. morphogenetic protein-4 signaling pathway involved in
8. Ek WE, Levine DM, D’Amato M, Pedersen NL, epithelial cell renewal along the radial axis of the intestine.
Magnusson PK, Bresso F, Onstad LE, Schmidt PT, Digestion 2008;77 Suppl 1:42-7.
Tornblom H, Nordenstedt H, Romero Y, Mayo Clinic 25. Mari L, Milano F, Parikh K, Straub D, Everts V, Hoeben KK,

126 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦